Sanofi recently announced that its respiratory syncytial virus (RSV) preventive treatment, Beyfortus, significantly reduced hospitalizations among infants in two RSV seasons. A study published in The...
A recent decision by the U.S. Centre for Disease Control (CDC) to reduce its routine vaccine recommendations for children has raised serious concerns among Canadian health...
Canadian healthcare professionals are expressing serious concerns over a new policy from the U.S. Centre for Disease Control (CDC) that significantly reduces the number of vaccines...
As the holiday season approaches, pharmacies and emergency rooms in the Edmonton area are experiencing a significant influx of patients suffering from respiratory illnesses, including Influenza,...
A recent study conducted by researchers at the University of British Columbia (UBC) has revealed that infants are disproportionately affected by hospitalizations due to Respiratory Syncytial...
The government of Nova Scotia has announced a new initiative to provide free respiratory syncytial virus (RSV) vaccines to infants under eight months old. This program...
